| |
|
|
| |
|
|
| |
Toronto
Institute of
Pharmaceutical Technology
55 Town Centre Crt. Suite
800
Toronto, Ontario
M1P 4X4, CANADA
Tel: (416) 296-1478
Fax: (416) 296-7077
Email: info@tipt.com |
|
|
|
|
| |
The Toronto
Institute of Pharmaceutical Technology (TIPT) as a pioneering Institute for practical education and training in industrial
pharmaceutical science has a tradition of excellence in pharmaceutical research, with emphasis on technology-enabling practical
projects, which characterizes our identity as much as our teaching expertise.
Our research emphasis is on advancing technological capabilities and understanding of pharmaceutical processes and drug delivery
systems for industrial applications to products of medicine and health care. There are four main divisions within our research
& development department:
|
|
| |
| |
Biopharmaceutics
|
|
| |
Our research activities in Biopharmaceutics focuses on drug pharmacokinetics, in-vivo/in-vitro relationships and the use of Design-of- Experiments (DOE) to predict and interpret drug absorption and pharmacodynamics. Current research examines ways to translate PK-PD elucidations of Class II and Class III biopharmaceutical compounds into new therapeutic benefits. [more...] |
|
|
|
|
| |
|
|
| |
| |
Formulation Sciences
|
|
| |
Our research activities focus on novel science and technologies to develop and understand dosage forms with scientific precision and performance predictability. Current research in formulation science includes the deployment of experimental designs (factorial and neural networks) in pre-formulation and formulation development. [more...] |
|
|
|
|
| |
|
|
| |
| |
Manufacturing Technology
|
|
| |
Our research activities focus on the sciences and technologies used to develop manufacturing processes as well as manufacturing scale-up models for the final dosage form of medicines [more...] |
|
|
|
|
| |
|
|
| |
| |
Drug Delivery
|
|
| |
Our research in drug delivery emphasizes the development of controlled oral drug delivery systems with potential benefits of patient compliance and reduced intra-subject variability. Current research examines ways of adaptive and extended release oral drug delivery systems for predictive release and absorption of therapeutic compounds. [more...] |
|
|
|
|
| |
|
|
| |
|
|
|
